Clinical trial No longer in our active list Interventional Ages 18 and up

Using virtual reality to manage pain after thoracoscopic surgery

Official title: Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain (VR-TSP)

Run by Guangdong Provincial People's Hospital · NCT06574451 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if virtual reality can help reduce pain for patients after they have thoracoscopic surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment215 (estimated)
SponsorGuangdong Provincial People's Hospital
Academic / other
Locations4 sites (Guangzhou, Guangdong and 3 other locations)
Trial IDNCT06574451 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have undergone thoracoscopic surgery and have a postoperative pain score of 4 or higher.

Probably not a fit

Patients with severe cognitive impairments or neurological conditions that affect their ability to use the virtual reality software may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness and safety of virtual reality software as an adjunct therapy for managing acute postoperative pain in patients who have undergone thoracoscopic surgery. A total of 215 patients will be enrolled and assessed for pain levels 24 hours post-surgery. Those with significant pain will be randomly assigned to either receive the virtual reality intervention or standard care without it. Pain evaluations will occur within 30 minutes of the intervention to determine its effectiveness.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management for patients recovering from thoracoscopic surgery.

How similar studies have gone: Previous studies have shown promise in using virtual reality for pain management, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1.Age greater than or equal to 18 years.

  2.Patients within 1 day after thoracoscopic surgery.

  3.Junior high school degree or above, Mandarin communication is unimpeded, with certain Internet knowledge and mobile phone reading and writing skills.

  4.The score of the numeric grading scale (NRS) at 24 hours postoperatively ≥ 4 points.

  5.Patients who are able to understand the purpose of the study, voluntarily participate in and sign the informed consent form, and are willing to complete the follow-up as required by the protocol.

Exclusion Criteria:

* 1.Patients with severe cognitive impairment.

  2.Patients with a previous diagnosis of epilepsy, dementia, migraine, or other neurological disease that may result in the inability to use postoperative analgesic adjuvant therapy software or that may have adverse effects.

  3.Patients who are unable to understand or speak Mandarin.

  4.Patients who have visual abnormalities, severe hearing impairment, or motion sickness, etc., and are unable to view VR.

  5.Patients with trauma to the eyes, face, or neck that prevents the comfortable use of the VR device.

  6.Patients with severe heart, liver, kidney, hematologic, digestive, nervous system diseases and malnutrition.

  7.Patients who have previously used virtual reality software for pain that has not responded to treatment.

  8.Patients with a history of severe alcohol abuse, long-term heavy drinking, and symptoms of alcohol dependence.

  9.Patients who have participated in any analgesic interventional study within the past 1 week.

  10.Females who are pregnant or plan to become pregnant during the study.

  11.The patient or their immediate family member works for a digital health or pharmaceutical company for acute or chronic pain treatment.

  12.Patients who are unable to use electronic devices such as smartphones.

  13.Other conditions that the investigator considers inappropriate for participation in a clinical trial.

Where it's running

  • Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences
    Guangzhou, Guangdong, China
    Recruiting
  • Maoming People's Hospital
    Maoming, Guangdong, China
    Recruiting
  • Ruijing Hospital, Shanghai Jiao Tong University
    Shanghai, Shanghai, China
    Recruiting
  • Tianjin Medical University General Hospital
    Tianjin, Tianjin, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.